NouriTech breaks ground on new plant to produce Calysta’s FeedKind protein at scale
In Tennessee, NouriTech, a venture formed through investments from Cargill, Calysta, Inc. and several third-party institutions, broke ground on a new thirty-seven acre plant...
Memphis Meats raises $17 million to make meat without the animal
In California, Memphis Meats raised $17 million from a group of investors including Bill Gates, Richard Branson and Cargill to continue developing delicious products,...
TerraVia receives FDA generally recognized as safe letter for Algae Butter
In California, TerraVia Holdings, Inc. received a generally recognized as safe no questions letter from the U.S. Food and Drug Administration for its Algae...
The Impossible Burger debuts on the West Coast
In California, Impossible Foods launched the Impossible Burger in selected West Coast restaurants. Not yet available in stores, the Impossible Burger is a result of...
i-Health acquires UP4 Probiotics to drive probiotic category leadership
In Connecticut, i-Health Inc. announced the purchase of the UP4 Probiotic brand from UAS Laboratories, LLC. The UP4 consumer brand incorporates state of the...
Copia Agro & Food announces a new $50 million agriculture and food investment fund
In Israel, the Copia Agro & Food fund announced it is raising $50 million to expand its investments in agricultural and food projects developed...
The Beyond Burger goes to Yale
In California, Beyond Meat, announced that its Beyond Burger will be available at Yale University’s thirteen on-campus dining halls; making the 315-year-old Ivy League...
Impossible Foods to make 1 million pounds of plant-based meat per month
In California, Impossible Foods launched its first large-scale production facility to make at least 1 million pounds of plant-based meat per month – enough...
USDA grants a license for the first monoclonal antibody therapy to control canine atopic...
In New Jersey, Zoetis Inc. announced that the U.S. Department of Agriculture granted a license for CYTOPOINT, the first monoclonal antibody therapy approved to...
Kaleido Biosciences and CoreBiome accelerate microbiome therapeutic discovery
In Massachusetts, Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, announced an agreement with CoreBiome, a...